焦虑和抑郁量表在肝硬化患者临床应用中的信效度评价*

doi:10.3969/j.issn.1672-5069.2019.01.028

实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (1): 105-108.doi: 10.3969/j.issn.1672-5069.2019.01.028

焦虑和抑郁量表在肝硬化患者临床应用中的信效度评价^*

田银娣, 王怡恺, 李静, 王苗苗, 党双锁

710004 西安市西安交通大学医学院第二附属医院感染病科

收稿日期:2018-04-16 出版日期:2019-01-10 发布日期:2019-01-16
通讯作者: 党双锁,E-mail:dang212@126.com
作者简介:田银娣,女,40岁,硕士研究生,主管护师。E-mail:xiari1979@163.com
基金资助:
*国家自然科学基金资助项目（编号：30670961）

Evaluation of reliability and validity of self-rating anxiety scale and self-rating depression scale in patients with liver cirrhosis

Tian Yindi, Wang Yikai, Li Jing, et al.

Department of Infectious Diseases,Second Affiliated Hospital,Medical College,Jiaotong University,Xi'an 710004,Shaanxi Province,China

Received:2018-04-16 Online:2019-01-10 Published:2019-01-16

摘要/Abstract

摘要： 目的应用焦虑自评量表（SAS）和抑郁自评量表（SDS）调查肝硬化患者心理障碍状况,评价其在肝硬化患者中应用的信效度。方法应用SAS和SDS量表对138例肝硬化患者进行问卷调查, 采用Cronbach’s α系数、分半系数、组内相关系数（ICC）反映量表的同质信度。采用探索性因子分析量表的结构效度,计算Kaiser-Meyer-Olkin（KMO）值,并作巴特利特球形检验（BTS）判断因子分析是否合适,采用主成分分析法提取因子。结果本组肝硬化患者焦虑和抑郁患病率分别为38.2%和63.1%;SAS量表的Cronbach’s α系数为0.777,SDS量表的Cronbach’s α系数为0.782,两个量表具有良好的同质性信度;分别对SAS量表提取4个主要因子,其方差解释比例分别为15.4%、14.9%、10.6%和10.2%,4个因子累计解释总方差的51.1%;对于SDS量表提取5个主要因子,其方差解释比例分别为14.0%、12.6%、11.9%、10.3%和8.4%,5个因子累计解释总方差的57.4%;SAS和SDS量表重测分析发现,两次测量结果高度相关（P<0.001）。结论应用SAS和SDS量表调查肝硬化患者焦虑和抑郁情况具有良好的信效度,可以用于肝硬化患者心理障碍的测定。

关键词: 肝硬化, 焦虑自评量表, 抑郁自评量表, 心理障碍, 信效度

Abstract: Objective This study was designed to evaluate of reliability and validity of self-rating anxiety scale（SAS） and self-rating depression scale（SDS） in patients with liver cirrhosis. Methods A total of 138 patients with liver cirrhosis were enrolled in this study. The reliability and validity of the two scales was evaluated by Cronbach’s α co-efficient,intraclass correlation co-efficient （ICC）,Kaiser-Meyer-Olkin （KMO） score and Bartlett’s test of sphericity（BTS）. Results The prevalence of anxiety and depression in this series were 38.2% and 63.1%,respectively;SAS scale’ Cronbach's α coefficient was 0.777 and SDS scale’ was 0.782, indicating better homogeneity reliability; Twenty items of SAS and SDS scales were analyzed by exploratory factors to construct validity and four main factors were extracted from the SAS scale that showed the variances ratio were 15.4%,14.9%,10.6% and 10.2%,respectively,and four factors accounted for 51.1% of the total variance of accumulated explanation;Five main factors were extracted from SDS scales that showed the variance ratio were 14.0%,12.6%,11.9%,10.3% and 8.4%,respectively,with 57.4% of the total variance;The re-measurement analysis of SAS and SDS scale’s items found that the two measurements were highly correlated with each other （P<0.001）. Conclusion SAS and SDS scales have a better reliability and validity in the investigation of psychological and mental impairment in patients with liver cirrhosis.

Key words: Liver cirrhosis, Anxiety, Depression, Reliability, Validity

田银娣, 王怡恺, 李静, 王苗苗, 党双锁. 焦虑和抑郁量表在肝硬化患者临床应用中的信效度评价^*[J]. 实用肝脏病杂志, 2019, 22(1): 105-108.

Tian Yindi, Wang Yikai, Li Jing, et al.. Evaluation of reliability and validity of self-rating anxiety scale and self-rating depression scale in patients with liver cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 105-108.

参考文献

[1] 王园园,钱湘云,居玲玲,等. 失代偿期乙型肝炎肝硬化患者负性情绪调查分析.中华现代护理杂志,2017,23(26):3400-3404.
[2] 林明霞,唐娜. 同理式沟通对失代偿期乙型肝炎肝硬化患者负性情绪的影响. 实用肝脏病杂志,2017,20(5):623-624.
[3] Zhao X,Zhao L,Lai Y,et al.Physiological and subjective responses after psychosocial stress in Chinese hepatitis B patients. Stress Health,2015,31(1):44-51.
[4] Gohier B,Goeb JL,Rannou-Dubas K,et al.Hepatitis C,alpha interferon,anxiety and depression disorders:a prospective study of 71patients. World J Biol Psychiatry,2003,4(3):115-118.
[5] Cinar S,Ozdogan OC,Alahdab Y.Impact of education provided by nurses on quality of life, anxiety, and depression in patients receiving hepatitis C virus therapy. Gastroenterol Nurs,2015,38(5):343-347.
[6] 居朝霞,吴桂香,张波,等. 院外延伸性护理对慢性丙型肝炎患者负性情感和自我效能的正性作用研究. 实用肝脏病杂志,2017,20(6):701-704.
[7] 张晓荣,王阁,胡格. 肝病患者伴发的抑郁焦虑症状及其治疗.中华肝脏病杂志,2002,10(3):192.
[8] 孙振晓,刘化学,焦林瑛,等. 医院焦虑抑郁量表的信度及效度研究. 中华临床医师杂志,2017,11(2):198-201.
[9] Ko FY,Tsai SJ,Yang AC,et al.Association of CD8 T cells with depression and anxiety in patients with liver cirrhosis. Int J Psychiatry Med,2013,45(1):15-29.
[10] Polis S,Fernandez R.Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis:a systematic review protocol.JBI Database System Rev Implement Rep,2015,13(1):39-51.
[11] Popovi DDj,ulafi DM,Tepavcevic DB,et al. Assessment of depression and anxiety in patients with chronic liver disease.Vojnosanit Pregl,2015,72(5):414-420.
[12] Zung WWK.A self-rating depression scale. Arch Gener Psych,1965,12:63-70.
[13] 刘丽英,王建荣,张秀,等. 慢性乙肝住院患者希望水平与焦虑抑郁情绪及社会支持的相关性.中华现代护理杂志,2012,18(16):1874-1876.
[14] Belvederi Murri M,Cecere AC,Masotti M,et al.Biopsychosocial predictors of interferon-related depression in patients with hepatitis C. Asian J Psychiatr,2017,26:24-28.
[15] Bakhshi Aliabad MH,Jafari E,Karimi Kakh M,et al.Anxiety leads to up-regulation of CD36 on the monocytes of chronic hepatitis B-infected patients. Int J Psychiatry Med,2016,51(5):467-475.
[16] Benzing C,Krezdorn N,Hinz A,et al.Mental status in patients before and after liver transplantation. Ann Transplant,2015,20:683-693.
[17] Keskin G,Gümüs AB,Orgun F.Quality of life,depression, and anxiety among hepatitis B patients. Gastroenterol Nurs,2013,36(5):346-356.
[18] Bitsika V,Sharpley C, Melham T.Gender differences in factor scores of anxiety and depression among Australian university students:Implications for counselling interventions. Can J Counsel,2010,44(1):51-64.
[19] Gutteling JJ,de Man RA,Busschbach JJ,et al. Overview of research on health-related quality of life in patients with chronic liver disease. Neth J Med,2007,65(7):227-234.
[20] Shafer A.Meta-analysis of the factor structures of four depression questionnaires:Beck,CES-D,Hamilton,and Zung. J Clin Psychol,2006,62(1):123-146.
[21] Haag S,Senf W,Hauser W,et al.Impairment of health-related quality of life in functional dyspepsia and chronic liver disease:the influence of depression and anxiety. Aliment Pharmacol Ther,2008,27(7):561-571.

焦虑和抑郁量表在肝硬化患者临床应用中的信效度评价^*

Evaluation of reliability and validity of self-rating anxiety scale and self-rating depression scale in patients with liver cirrhosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	庄莹, 林志辉. 肝硬化并发门静脉血栓临床表现和诊断进展[J]. 实用肝脏病杂志, 2019, 22(6): 765-767.
[2]	杨才勇, 陈娜, 李奎, 江自成, 卜蓉蓉. 慢性丙型肝炎和丙型肝炎肝硬化患者外周血Treg和Th17水平变化临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 868-871.
[3]	朱娅鸽, 刘锦峰. 丁二磺酸腺苷蛋氨酸联合复方甘草酸苷治疗酒精性肝硬化患者疗效及其对血清BGP水平的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 872-875.
[4]	武丹, 马向鹰. 非酒精性脂肪性肝病肝硬化患者胰岛素抵抗水平与颈动脉硬化程度和左心室功能研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 876-879.
[5]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[6]	刘李, 杨烈, 陈海洋, 何承俊, 王建宇, 陈廷昊. 肝硬化门静脉高压症并发脾动脉盗血综合征患者脾切除联合贲门周围血管离断术后门脉血流动力学的变化^*[J]. 实用肝脏病杂志, 2019, 22(6): 884-887.
[7]	何志安, 余丽萍, 赖江琼, 黄思付. ARFI评估肝硬化并发食管胃底静脉曲张患者出血和门静脉血栓的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 888-891.
[8]	王月圆, 王燕, 张丹丹. 奥曲肽辅助特利加压素治疗失代偿期肝硬化并发肝肾综合征患者疗效分析*[J]. 实用肝脏病杂志, 2019, 22(5): 684-687.
[9]	张梅, 石秀英, 李林娟, 薛亚妮. 肝源性糖尿病患者肝组织干扰素诱导蛋白-10表达变化*[J]. 实用肝脏病杂志, 2019, 22(5): 688-691.
[10]	丹珠永吉, 刘芝兰, 禄艳艳, 蒋汉梅. 内镜下序贯套扎和硬化剂治疗肝硬化并发食管胃底静脉曲张破裂出血患者疗效及对血流动力学的影响对比研究*[J]. 实用肝脏病杂志, 2019, 22(5): 692-695.
[11]	黄汉军, 鲁凤荣, 张灿. 基于Exchange血流动力学模型的MRI扫描参数诊断肝硬化临床价值分析*[J]. 实用肝脏病杂志, 2019, 22(5): 696-699.
[12]	赵芳芳, 翟永贞, 冯国和. 自体外周血干细胞移植治疗乙型肝炎肝硬化患者疗效及安全性分析[J]. 实用肝脏病杂志, 2019, 22(5): 700-703.
[13]	陈山, 庄华帅, 邢诒喜, 吴直佳. 美罗培南治疗肝硬化并发上消化道出血患者对感染预防和再出血的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 704-707.
[14]	徐祺林, 郝少欢, 冉博. 肝硬化脾切除术后门静脉系统血栓形成的危险因素分析*[J]. 实用肝脏病杂志, 2019, 22(5): 708-711.
[15]	金良红, 李兴杰, 关红博, 麻少辉. 双能量CT碘定量结合动态对比增强MRI评估肝硬化患者肝脏血流动力学和肝功能临床价值研究*[J]. 实用肝脏病杂志, 2019, 22(5): 712-715.